Trial Profile
Phase III study of lenalidomide in post-stem cell transplant patients with newly diagnosed multiple myeloma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 19 Jan 2015 New trial record
- 12 Jan 2015 According to a Celgene Corporation media release, this trial is expected to initiate in 2015.